Prof.Dr.med. ID: 63635
Victor-Felix Mautner
Publications
- 2018
Dorsal root ganglia in vivo morphometry and perfusion in female patients with Fabry disease
Godel, T., Köhn, A., Muschol, N., Kronlage, M., Schwarz, D., Kollmer, J., Heiland, S., Bendszus, M., Mautner, V-F. & Bäumer, P., 11.2018, In: J NEUROL. 265, 11, p. 2723-2729 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas
Kehrer-Sawatzki, H., Kluwe, L., Friedrich, R. E., Summerer, A., Schäfer, E., Wahlländer, U., Matthies, C., Gugel, I., Farschtschi, S., Hagel, C., Cooper, D. N. & Mautner, V-F., 07.2018, In: HUM GENET. 137, 6-7, p. 543-552 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1
Sellmer, L., Farschtschi, S., Marangoni, M., Heran, M. K. S., Birch, P., Wenzel, R., Mautner, V-F. & Friedman, J. M., 23.04.2018, In: ORPHANET J RARE DIS. 13, p. 62Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Dorsal root ganglia volume differentiates schwannomatosis and neurofibromatosis 2
Godel, T., Mautner, V-F., Farschtschi, S., Pham, M., Schwarz, D., Kronlage, M., Gugel, I., Heiland, S., Bendszus, M. & Bäumer, P., 04.2018, In: ANN NEUROL. 83, 4, p. 854-857 4 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunities
Schulz, A., Grafe, P., Hagel, C., Bäumer, P., Morrison, H., Mautner, V-F. & Farschtschi, S., 01.01.2018, In: EXP NEUROL. 299, Pt B, p. 334-344 11 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Cerebrovascular Insult as Presenting Symptom of Neurofibromatosis Type 2 in Children, Adolescents, and Young Adults
Gugel, I., Mautner, V-F., Kluwe, L., Tatagiba, M. S. & Schuhmann, M. U., 2018, In: FRONT NEUROL. 9, p. 733Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2017
Human dorsal root ganglion in vivo morphometry and perfusion in Fabry painful neuropathy
Godel, T., Bäumer, P., Pham, M., Köhn, A., Muschol, N., Kronlage, M., Kollmer, J., Heiland, S., Bendszus, M. & Mautner, V-F., 19.09.2017, In: NEUROLOGY. 89, 12, p. 1274-1282 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells
Fischer-Huchzermeyer, S., Dombrowski, A., Hagel, C., Mautner, V. F., Schittenhelm, J. & Harder, A., 01.07.2017, In: AM J PATHOL. 187, 7, p. 1623-1632Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2
Farschtschi, S., Gelderblom, M., Buschbaum, S., Bostock, H., Grafe, P. & Mautner, V. F., 03.2017, In: MUSCLE NERVE. 55, 3, p. 350-358Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Non-optic glioma in adults and children with neurofibromatosis 1
Sellmer, L., Farschtschi, S., Marangoni, M., Heran, M. K. S., Birch, P., Wenzel, R., Friedman, J. M. & Mautner, V-F., 15.02.2017, In: ORPHANET J RARE DIS. 12, 1, p. 34Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis
Kehrer-Sawatzki, H., Farschtschi, S., Mautner, V-F. & Cooper, D. N., 02.2017, In: HUM GENET. 136, 2, p. 129-148Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Therapie und Verlauf neurologischer Erkrankungen: Kapitel H7: Neurokutane Syndrome
Farschtschi, S. C., Tatagiba, M. & Mautner, V-F., 2017, Therapie und Verlauf neurologischer Erkrankungen. Diener, H-C., Gerloff, C. & Dieterich, M. (eds.). 7 ed. Stuttgart: Kohlhammer, p. 997 - 1006 10 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education › peer-review
- 2016
The putative oncogene CPI-17 is up-regulated in schwannoma
Hagel, C., Dornblut, C., Schulz, A., Wiehl, U., Friedrich, R. E., Huckhagel, T., Mautner, V-F. & Morrison, H., 12.2016, In: NEUROPATH APPL NEURO. 42, 7, p. 664-668Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Muskelaktionspotenzial-Scan und Ultraschall zur Erfassung der Neuropathie bei der Neurofibromatose Typ 2
Farschtschi, S. C., Gelderblom, M., Buschbaum, S., Bostock, H., Grafe, P. & Mautner, V-F., 19.11.2016, 20. Tagung der Arbeitsgemeinschaft Neurofibromatose.Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research
Multifocal Nerve Lesions and LZTR1 Germline Mutations in Segmental Schwannomatosis
Farschtschi, S., Mautner, V-F., Pham, M., Nguyen, R., Kehrer-Sawatzki, H., Hutter, S., Friedrich, R. E., Schulz, A., Morrison, H., Jones, D. T. W., Bendszus, M. & Bäumer, P., 10.2016, In: ANN NEUROL. 80, 4, p. 625-8Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients
Farschtschi, S., Park, S-J., Sawitzki, B., Oh, S-J., Kluwe, L., Mautner, V. F. & Kurtz, A., 09.2016, In: CANCER IMMUNOL IMMUN. 65, 9, p. 1113-1121Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis
Ahlawat, S., Fayad, L. M., Khan, M. S., Bredella, M. A., Harris, G. J., Evans, D. G., Farschtschi, S., Jacobs, M. A., Chhabra, A., Salamon, J. M., Wenzel, R., Mautner, V. F., Dombi, E., Cai, W., Plotkin, S. R., Blakeley, J. O. & Whole Body MRI Committee for the REiNS International Collaboration, 16.08.2016, In: NEUROLOGY. 87, 7 Suppl 1, p. S31-9Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2
Farschtschi, S., Merker, V. L., Wolf, D., Schuhmann, M., Blakeley, J., Plotkin, S. R., Hagel, C. & Mautner, V. F., 06.2016, In: ACTA NEUROL SCAND. 133, 6, p. 475-480Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The importance of nerve microenvironment for schwannoma development
Schulz, A., Büttner, R., Hagel, C., Baader, S. L., Kluwe, L., Salamon, J., Mautner, V-F., Mindos, T., Parkinson, D. B., Gehlhausen, J. R., Clapp, D. W. & Morrison, H., 28.05.2016, In: ACTA NEUROPATHOL. 132, 2, p. 289-307Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Recurrent Multilocular Mandibular Giant Cell Granuloma in Neurofibromatosis Type 1: Evidence for Second Hit Mutation of NF1 Gene in the Jaw Lesion and Treatment with Curettage and Bone Substitute Materials
Friedrich, R., Grob, T., Hollants, S., Zustin, J., Spaepen, M., Mautner, V-F., Lübke, A., Hagel, C., Legius, E. & Brems, H., 15.05.2016, In: J CRANIO MAXILL SURG. 44, 8, p. 1054-1060Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients
Hutter, S., Piro, R. M., Waszak, S. M., Kehrer-Sawatzki, H., Friedrich, R. E., Lassaletta, A., Witt, O., Korbel, J. O., Lichter, P., Schuhmann, M. U., Pfister, S. M., Tabori, U., Mautner, V. F. & Jones, D. T. W., 05.2016, In: HUM GENET. 135, 5, p. 469-75 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Schwannomatose
Mautner, V-F. & Farschtschi, S. C., 2016, Ratgeber Schwannomatose: Schwannomatose. 1 ed. Hamburg: Bundesverband Neurofibromatose e.V., 27 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education
- 2015
Unilateral gynaecomastia in a 16-month-old boy with neurofibromatosis type 1 - case report and brief review of the literature
Friedrich, R. E., Hagel, C. & Mautner, V-F., 03.12.2015, In: GMS INTERDISCIP PLAS. 4, p. Doc11Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Nerve Sheath Tumors in Neurofibromatosis Type 1: Hannover Med Sch, Dept Nucl Med, Hannover, Germany
Salamon, J., Papp, L., Tóth, Z., Laqmani, A., Apostolova, I., Adam, G., Mautner, V. F. & Derlin, T., 01.12.2015, In: PLOS ONE. 10, 12, p. e0143305Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Ipsilateral Sphenoid Wing Dysplasia, Orbital Plexiform Neurofibroma and Fronto-Parietal Dermal Cylindroma in a Patient with Segmental Neurofibromatosis
Friedrich, R. E., Hagel, C. & Mautner, V-F., 12.2015, In: ANTICANCER RES. 35, 12, p. 6813-8 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors
Salamon, J., Mautner, V. F., Adam, G. & Derlin, T., 12.2015, In: ROFO-FORTSCHR RONTG. 187, 12, p. 1084-1092 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2
Farschtschi, S., Kollmann, P., Dalchow, C., Stein, A. & Mautner, V-F., 12.2015, In: EUR ARCH OTO-RHINO-L. 272, 12, p. 3857-60 4 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Cerebral glucose metabolism in adults with neurofibromatosis type 1
Apostolova, I., Derlin, T., Salamon, J., Amthauer, H., Granström, S., Brenner, W., Mautner, V-F. & Buchert, R., 02.11.2015, In: BRAIN RES. 1625, p. 97-101 5 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Impairment of Procedural Learning and Motor Intracortical Inhibition in Neurofibromatosis Type 1 Patients
Zimerman, M., Wessel, M. J., Timmermann, J. E., Granström, S., Gerloff, C., Mautner, V-F. & Hummel, F., 01.09.2015, In: EBIOMEDICINE. 2, 10, p. 1430-1437Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Foreign Body Abscess Mimicking a Malignant Peripheral Nerve Sheath Tumor in a Patient With Neurofibromatosis Type 1
Salamon, J., Hagel, C., Friedrich, R. E., Mautner, V-F. & Derlin, T., 08.2015, In: CLIN NUCL MED. 40, 8, p. 674-675Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits
Apostolova, I., Niedzielska, D., Derlin, T., Koziolek, E. J., Amthauer, H., Salmen, B., Pahnke, J., Brenner, W., Mautner, V. F. & Buchert, R., 08.2015, In: J CEREBR BLOOD F MET. 35, 8, p. 1304-12 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1
Jett, K., Nguyen, R., Arman, D., Birch, P., Chohan, H., Farschtschi, S., Fuensterer, C., Kluwe, L., Friedman, J. M. & Mautner, V. F., 07.2015, In: AM J MED GENET A. 167, 7, p. 1518-24 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Growth in neurofibromatosis 1 microdeletion patients
Ning, X., Farschtschi, S., Jones, A., Kehrer-Sawatzki, H., Mautner, V-F. & Friedman, J. M., 26.06.2015, In: CLIN GENET. 89, 3, p. 351-354Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Determination of the mutant allele frequency in patients with neurofibromatosis type 2 and somatic mosaicism by means of deep sequencing
Spyra, M., Otto, B., Schön, G., Kehrer-Sawatzki, H. & Mautner, V-F., 29.05.2015, In: GENE CHROMOSOME CANC. 54, 8, p. 482-488Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures
Wei, J., Mautner, V. F., Friedrich, R. E. & Kluwe, L., 04.2015, In: J CLIN NEUROL. 11, 2, p. 172-7 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation
Farschtschi, S., Mautner, V-F., Hollants, S., Hagel, C., Spaepen, M., Schulte, C., Legius, E. & Brems, H., 01.01.2015, In: BMC MED GENET. 16, 1, p. 6Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Faszikuläre Mikroläsionen und Neuropathie bei der Schwannomatose
Farschtschi, S. C., Bäumer, P., Anna-Lena, H., Hauck, M., Gelderblom, M., Peter, G., Pham, M. & Mautner, V-F., 2015, 88. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research
Impact of ADHD in Adults With Neurofibromatosis Type 1: Associated Psychological and Social Problems.
Mautner, V. F., Granström, S. & Leark, R. A., 2015, In: J ATTEN DISORD. 19, 1, p. 35-43Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Multiple Parameter der Nervenerregbarkeit bei der NF2
Peter, G., Farschtschi, S. C., Bostock, H. & Mautner, V-F., 2015, 88. Kongress der Deutschen Gesellschaft für Neurologie mit Fortbildungsakademie.Research output: SCORING: Contribution to book/anthology › Conference contribution - Poster › Research
- 2014
Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants
Hutter, S., Piro, R. M., Reuss, D. E., Hovestadt, V., Sahm, F., Farschtschi, S., Kehrer-Sawatzki, H., Wolf, S., Lichter, P., von Deimling, A., Schuhmann, M. U., Pfister, S. M., Jones, D. T. W. & Mautner, V. F., 01.09.2014, In: ACTA NEUROPATHOL. 128, 3, p. 449-52 4 p.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Influence of learning disabilities on the tumour predisposition syndrome NF1--survey from adult patients' perspective
Granström, S., Friedrich, R. E., Langenbruch, A. K., Augustin, M. & Mautner, V-F., 01.07.2014, In: ANTICANCER RES. 34, 7, p. 3675-81 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms
Reuss, D. E., Habel, A., Hagenlocher, C., Mucha, J., Ackermann, U., Tessmer, C., Meyer, J., Capper, D., Moldenhauer, G., Mautner, V-F., Frappart, P-O., Schittenhelm, J., Hartmann, C., Hagel, C., Katenkamp, K., Petersen, I., Mechtersheimer, G. & von Deimling, A., 01.04.2014, In: ACTA NEUROPATHOL. 127, 4, p. 565-72 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off
Salamon, J., Veldhoen, S., Apostolova, I., Bannas, P., Yamamura, J., Herrmann, J., Friedrich, R. E., Adam, G., Mautner, V-F. & Derlin, T., 01.02.2014, In: EUR RADIOL. 24, 2, p. 405-12 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Analysis of crossover breakpoints yields new insights into the nature of the gene conversion events associated with large NF1 deletions mediated by nonallelic homologous recombination
Bengesser, K., Vogt, J., Mussotter, T., Mautner, V-F., Messiaen, L., Cooper, D. N. & Kehrer-Sawatzki, H., 01.02.2014, In: HUM MUTAT. 35, 2, p. 215-26 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling
Schulz, A., Kyselyova, A., Baader, S. L., Jung, M. J., Zoch, A., Mautner, V-F., Hagel, C. & Morrison, H., 01.02.2014, In: BRAIN. 137, 2, p. 420-32 13 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Syndromale abdominale Ganglioneurome: eine seltene Ursache falsch-positiver Befunde in der F-18-FDG PET/CT bei Neurofibromatose Typ 1
Derlin, T., Hagel, C. & Mautner, V. F., 09.01.2014, In: ROFO-FORTSCHR RONTG. 186, 7, p. 706-707Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Efficacy and selectivity of nilotinib on NF1-associated tumors in vitro
Wei, J., Schnabel, C., Spyra, M., Mautner, V-F., Friedrich, R. E., Hagel, C., Manley, P. W. & Kluwe, L., 01.01.2014, In: J NEURO-ONCOL. 116, 2, p. 231-6 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo
Wei, J., Freytag, M., Schober, Y., Nockher, W. A., Mautner, V-F., Friedrich, R. E., Manley, P. W., Kluwe, L. & Kurtz, A., 01.01.2014, In: PLOS ONE. 9, 10, p. e107760Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
Nguyen, R., Jett, K., Harris, G. J., Cai, W., Friedman, J. M. & Mautner, V-F., 2014, In: J NEURO-ONCOL. 116, 2, p. 307-313 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Neurokutane Erkrankungen
Panteliadis, C. P., Hagel, C., Mautner, V-F., Friedrich, R. & Rosenbaum, T., 2014, Neuropädiatrie - Evidenzbasierte Therapie. 2 ed. Elsevier, 27 p.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education